Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the ?-Catenin/TCF/LEF-1 pathway in gastric cancer cells.
Ontology highlight
ABSTRACT: Glycogen synthase kinase 3 beta (GSK3?) is a critical protein kinase that phosphorylates numerous proteins in cells and thereby impacts multiple pathways including the ?-Catenin/TCF/LEF-1 pathway. MicroRNAs (miRs) are a class of noncoding small RNAs of ?22 nucleotides in length. Both GSK3? and miR play myriad roles in cell functions including stem cell development, apoptosis, embryogenesis and tumorigenesis. Here we show that GSK3? inhibits the expression of miR-96, miR-182 and miR-183 through the ?-Catenin/TCF/LEF-1 pathway. Knockout of GSK3? in mouse embryonic fibroblast cells increases expression of miR-96, miR-182 and miR-183, coinciding with increases in the protein level and nuclear translocation of ?-Catenin. In addition, overexpression of ?-Catenin enhances the expression of miR-96, miR-182 and miR-183 in human gastric cancer AGS cells. GSK3? protein levels are decreased in human gastric cancer tissue compared with surrounding normal gastric tissue, coinciding with increases of ?-Catenin protein, miR-96, miR-182, miR-183 and primary miR-183-96-182 cluster (pri-miR-183). Furthermore, suppression of miR-183-96-182 cluster with miRCURY LNA miR inhibitors decreases the proliferation and migration of AGS cells. Knockdown of GSK3? with siRNA increases the proliferation of AGS cells. Mechanistically, we show that ?-Catenin/TCF/LEF-1 binds to the promoter of miR-183-96-182 cluster gene and thereby activates the transcription of the cluster. In summary, our findings identify a novel role for GSK3? in the regulation of miR-183-96-182 biogenesis through ?-Catenin/TCF/LEF-1 pathway in gastric cancer cells.
SUBMITTER: Tang X
PROVIDER: S-EPMC3950676 | biostudies-literature | 2014 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA